1 / 14

Comprehensive Bio molecular Databases: a worldwide cooperation ?

Comprehensive Bio molecular Databases: a worldwide cooperation ?. Stéphane Nauche http://www.linkedin.com/in/snauche Ana Richart de la Torre. http://images.nigms.nih.gov/.

emi-whitley
Télécharger la présentation

Comprehensive Bio molecular Databases: a worldwide cooperation ?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Comprehensive Bio molecular Databases: a worldwide cooperation ? Stéphane Nauche http://www.linkedin.com/in/snauche Ana Richart de la Torre http://images.nigms.nih.gov/ The SLING project is funded by the European Commission within Research Infrastructures of the FP7 Capacities Specific Programme, grant agreement number 226073 (Integrating Activity)

  2. Historical Background

  3. Sequence Listing Description Claims SA0000001 Sequence Listing Figures

  4. Sequence Listing

  5. WIPO ST 25 SEQUENCE LISTING <110> Lohmann Tierzucht <120> marker assisted selection of chiken against fishy taint in fresh eggs <130>Sequence Listing example <140> EP04022858.7 <141> 2004-09-24 <150> EP03021556.0 <151> 2003-09-24 <160> 25 <170> PatentIn Ver. 2.1 <210> 1 <211> 135 <212> DNA <213> Gallus gallus <220> <221> primer_bind <222>1..20 <223> /note= "CF3ex1for primer bind site" <220> <221> primer_bind <222>116..125 <223> /note= "CF3ex2rev primer bind site" <220> <221> variation <222>90..90 <223> /replace= t /note= "variation in exon 1-2" <400> 1 atggtgcgac gcgtggctgt ggtgggcgcg ggcatcagcg ggttggcggc caccaagtgc 60 tgcctggaag agggactgga gcccacctgc tttgagcaga gcgaggacat cggggggctc 120 tggcgctaca cggaa 135 Applicant Name Title of invention File reference Current Patent application Current filing date Earlier patent application Earlier filing date Number of SEQ IDs in SL Software use to prepare SL Information for SEQ ID 1 Length of SEQ ID 1 Sequence Type Source Organism Feature Header Feature key Location Feature information with standardized qualifiers Feature Header Feature key Location Feature information with standardized qualifiers Feature Header Feature key Location Feature information with standardized qualifiers Sequence Information linking the SL with the patent application Latin name (Genus- Species) of the sequence source organism Position in the sequence for which the feature applies Feature Key: using standardized vocabulary Feature Qualifier preceded by a / and followed by the =

  6. XML Sequence Listing General Information Sequence Part

  7. Date Stamp Business rules Business rules Business rules Search Environment "Scientific" Publication server Verified Sequences Relational Database Online filing Verification Formatting "Non redundant" Patent Sequence Database Process Temp Repository Legal Publication server Sequence Listing files (ST25) Phoenix/ Madras Storage of all incoming sequence listing files including versions (Legal version) Front End Populating Databases Paper Filing and Sequence Listing on Electronic carrier Sequence Listings from National Patent Offices

  8. USPTO JPO EPO KIPO International Cooperation WIPO SIPO Etc.. NO NO EPC NO NO

  9. Necessity to increase coverage and avoid redundant Information • Increase in Biotechnology applications disclosing biological sequences. • To date, only JPO, USPTO, EPO and KIPO, send their sequences to the public repositories (NCBI/DDBJ/EBI) • Data spreading from other patent offices is not included in the exchange flow. • June 2003: completeness study performed by the EPO. • (NCBI/DDBJ/EBI) vs. GeneSeq = Differences in coverage were detected :none is exhaustive ! • April 2005 (Washington): Project initiation report presented by the EPO to TO's • Aims: generation of Non-redundant Patent sequence databases with increased coverage • (Tokyo, April 2007, Munich, November 2007 and Washington 2009): • EPO progresses were presented to the TO's • JPO involved KIPO in the data exchange flow to the public sequence repositories • EPO and EBI have completed the generation of Non-redundant Patent sequence Databases, which are publicly available through the EBI services

  10. Patent Sequence Databases Figures August 2010 : 17 million entries

  11. Patent Sequence Databases Figures

  12. Open Innovation Harvard Business Review, 2004, Huston et al.“ MIT Sloan Management Review; 2007; Chesbrough h; „Why Companies should have open Business Models“

  13. Summary Create sequences Collect Populate Patent sequence databases Disseminate Information Search ‚Prior art‘ in Biotechnology

  14. Questions Thank You http://images.nigms.nih.gov/

More Related